Details
Stereochemistry | ACHIRAL |
Molecular Formula | 2F.Sn |
Molecular Weight | 156.707 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[F-].[F-].[SnH2++]
InChI
InChIKey=NKCWZXPMTVCPSF-UHFFFAOYSA-L
InChI=1S/2FH.Sn.2H/h2*1H;;;/q;;+2;;/p-2
Molecular Formula | Sn |
Molecular Weight | 118.71 |
Charge | 2 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | F |
Molecular Weight | 18.9984 |
Charge | -1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: http://www.codifa.it/farmaci/e/elmex-gel-dentale-gel-olaflur-e-dectaflur-e-sodio-fluoruro-anticariehttps://www.ncbi.nlm.nih.gov/pubmed/24604256Curator's Comment: description was created based on several sources, including
https://www.drugs.com/international/olaflur.html | https://www.ncbi.nlm.nih.gov/pubmed/15528912 | https://clinicaltrials.gov/ct2/show/record/NCT00268138 | https://www.old.health.gov.il/units/pharmacy/trufot/alonim/4872.pdf
Sources: http://www.codifa.it/farmaci/e/elmex-gel-dentale-gel-olaflur-e-dectaflur-e-sodio-fluoruro-anticariehttps://www.ncbi.nlm.nih.gov/pubmed/24604256
Curator's Comment: description was created based on several sources, including
https://www.drugs.com/international/olaflur.html | https://www.ncbi.nlm.nih.gov/pubmed/15528912 | https://clinicaltrials.gov/ct2/show/record/NCT00268138 | https://www.old.health.gov.il/units/pharmacy/trufot/alonim/4872.pdf
Oleylamine (or oleamine) is a versatile and flexible reagent in synthesis as well as the desired surface ligand for the synthesis of nanoparticles. This compound is rather toxic to mammalian organism.
CNS Activity
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
An improved method for emergent decontamination of ocular and dermal hydrofluoric acid splashes. | 2004 Aug |
|
Epidemiology of 377 patients with chemical burns in Guangdong province. | 2004 Sep |
|
Successful extracorporeal life support after potentially fatal pulmonary oedema caused by inhalation of nitric and hydrofluoric acid fumes. | 2007 Oct |
|
Sensitivity of human dental pulp cells to eighteen chemical agents used for endodontic treatments in dentistry. | 2013 Jan |
|
Oleylamine as a beneficial agent for the synthesis of CoFe₂O₄ nanoparticles with potential biomedical uses. | 2014 May 7 |
|
Cytotoxicity of organic surface coating agents used for nanoparticles synthesis and stability. | 2015 Jun |
|
Allergic contact cheilitis caused by olaflur in toothpaste. | 2017 Jan |
Patents
Sample Use Guides
Brushing your teeth thoroughly with the preparation once a week. Just use elmex dental gel using a regular toothbrush for a period of 2-3 minutes, rinse normally. The total time of application (brushing and residence time) should not exceed five minutes.
Route of Administration:
Dental
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3183150
The outer 50-100 mkm of the surface of freshly extracted human incisors was removed by grinding and polishing, thus removing not only the pellicle from the surface but also the outer mineral layer, which in general shows the greatest variation in chemical constituents. Amine fluoride 297 (AmF 297) were dissolved in distilled water. After adsorption of aminefluorides on the enamel for 2 min at a volume to area ratio of 25 cm3/cm2, the enamel surfaces were rinsed with distilled water and allowed to dry for several hours at room temperature in an enclosed chamber. Subsequently adsorbed layer thicknesses were determined by ellipsometry, and surface free energies were calculated from contact angle data.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:30:57 GMT 2023
by
admin
on
Fri Dec 15 15:30:57 GMT 2023
|
Record UNII |
3FTR44B32Q
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
A01AA04
Created by
admin on Fri Dec 15 15:30:57 GMT 2023 , Edited by admin on Fri Dec 15 15:30:57 GMT 2023
|
||
|
CFR |
21 CFR 355.60
Created by
admin on Fri Dec 15 15:30:57 GMT 2023 , Edited by admin on Fri Dec 15 15:30:57 GMT 2023
|
||
|
CFR |
21 CFR 355.55
Created by
admin on Fri Dec 15 15:30:57 GMT 2023 , Edited by admin on Fri Dec 15 15:30:57 GMT 2023
|
||
|
CFR |
21 CFR 355.50
Created by
admin on Fri Dec 15 15:30:57 GMT 2023 , Edited by admin on Fri Dec 15 15:30:57 GMT 2023
|
||
|
CFR |
21 CFR 355.10
Created by
admin on Fri Dec 15 15:30:57 GMT 2023 , Edited by admin on Fri Dec 15 15:30:57 GMT 2023
|
||
|
CFR |
21 CFR 355.70
Created by
admin on Fri Dec 15 15:30:57 GMT 2023 , Edited by admin on Fri Dec 15 15:30:57 GMT 2023
|
||
|
NCI_THESAURUS |
C28394
Created by
admin on Fri Dec 15 15:30:57 GMT 2023 , Edited by admin on Fri Dec 15 15:30:57 GMT 2023
|
||
|
WHO-VATC |
QA01AA04
Created by
admin on Fri Dec 15 15:30:57 GMT 2023 , Edited by admin on Fri Dec 15 15:30:57 GMT 2023
|
||
|
CFR |
21 CFR 355.20
Created by
admin on Fri Dec 15 15:30:57 GMT 2023 , Edited by admin on Fri Dec 15 15:30:57 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
783
Created by
admin on Fri Dec 15 15:30:57 GMT 2023 , Edited by admin on Fri Dec 15 15:30:57 GMT 2023
|
PRIMARY | |||
|
SUB15374MIG
Created by
admin on Fri Dec 15 15:30:57 GMT 2023 , Edited by admin on Fri Dec 15 15:30:57 GMT 2023
|
PRIMARY | |||
|
C77058
Created by
admin on Fri Dec 15 15:30:57 GMT 2023 , Edited by admin on Fri Dec 15 15:30:57 GMT 2023
|
PRIMARY | |||
|
134688170
Created by
admin on Fri Dec 15 15:30:57 GMT 2023 , Edited by admin on Fri Dec 15 15:30:57 GMT 2023
|
PRIMARY | |||
|
3FTR44B32Q
Created by
admin on Fri Dec 15 15:30:57 GMT 2023 , Edited by admin on Fri Dec 15 15:30:57 GMT 2023
|
PRIMARY | |||
|
10030
Created by
admin on Fri Dec 15 15:30:57 GMT 2023 , Edited by admin on Fri Dec 15 15:30:57 GMT 2023
|
PRIMARY | RxNorm | ||
|
DB11092
Created by
admin on Fri Dec 15 15:30:57 GMT 2023 , Edited by admin on Fri Dec 15 15:30:57 GMT 2023
|
PRIMARY | |||
|
DTXSID6064822
Created by
admin on Fri Dec 15 15:30:57 GMT 2023 , Edited by admin on Fri Dec 15 15:30:57 GMT 2023
|
PRIMARY | |||
|
4273
Created by
admin on Fri Dec 15 15:30:57 GMT 2023 , Edited by admin on Fri Dec 15 15:30:57 GMT 2023
|
PRIMARY | |||
|
231-999-3
Created by
admin on Fri Dec 15 15:30:57 GMT 2023 , Edited by admin on Fri Dec 15 15:30:57 GMT 2023
|
PRIMARY | |||
|
7783-47-3
Created by
admin on Fri Dec 15 15:30:57 GMT 2023 , Edited by admin on Fri Dec 15 15:30:57 GMT 2023
|
PRIMARY | |||
|
m10181
Created by
admin on Fri Dec 15 15:30:57 GMT 2023 , Edited by admin on Fri Dec 15 15:30:57 GMT 2023
|
PRIMARY | Merck Index | ||
|
3FTR44B32Q
Created by
admin on Fri Dec 15 15:30:57 GMT 2023 , Edited by admin on Fri Dec 15 15:30:57 GMT 2023
|
PRIMARY | |||
|
Tin(II) fluoride
Created by
admin on Fri Dec 15 15:30:57 GMT 2023 , Edited by admin on Fri Dec 15 15:30:57 GMT 2023
|
PRIMARY | |||
|
100000077812
Created by
admin on Fri Dec 15 15:30:57 GMT 2023 , Edited by admin on Fri Dec 15 15:30:57 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
|
||
|
PARENT -> SALT/SOLVATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|